A carregar...
Lasofoxifene (CP-336,156), a novel selective estrogen receptor modulator, in preclinical studies
Estrogen replacement therapy is reported to reduce the incidence of vertebral fractures in postmenopausal women, however, its compliance is limited because of side effects and safety concerns. Estrogen’s side effects on breast and uterine tissues leading to the potential increased risk of uterine an...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Kluwer Academic Publishers
2002
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3455753/ https://ncbi.nlm.nih.gov/pubmed/23604900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-002-0007-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|